Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19.
作者信息
Spinoni Enrico Guido, Mennuni Marco, Rognoni Andrea, Grisafi Leonardo, Colombo Crizia, Lio Veronica, Renda Giulia, Foglietta Melissa, Petrilli Ivan, D'Ardes Damiano, Sainaghi Pier Paolo, Aimaretti Gianluca, Bellan Mattia, Castello Luigi, Avanzi Gian Carlo, Corte Francesco Della, Krengli Marco, Pirisi Mario, Malerba Mario, Capponi Andrea, Gallina Sabina, Pierdomenico Sante Donato, Cipollone Francesco, Patti Giuseppe
机构信息
Università del Piemonte Orientale, Novara (E.G.S., L.G., C.C., V.L., P.P.S., G.A., M.B., L.C., G.C.A., F.D.C., M.K., M.P., M. Malerba, G.P.).
Maggiore della Carità Hospital, Novara (E.G.S., M. Mennuni, A.R., L.G., C.C., V.L., P.P.S., G.A., M.B., L.C., G.C.A., F.D.C., M.K., M.P., A.C., G.P.).
出版信息
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009375. doi: 10.1161/CIRCEP.120.009375. Epub 2021 Feb 16.
Abstract
摘要
相似文献
1
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19.心房颤动对新型冠状病毒肺炎患者院内死亡率的影响
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009375. doi: 10.1161/CIRCEP.120.009375. Epub 2021 Feb 16.
2
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.与 COVID-19 住院患者的心房心律失常相关的结局和死亡率。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3077-3085. doi: 10.1111/jce.14770. Epub 2020 Oct 14.
3
QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染患者群体中的QTc间期与死亡率
Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008890. doi: 10.1161/CIRCEP.120.008890. Epub 2020 Sep 29.
4
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection.心房颤动是因感染 SARS-CoV-2 而住院的患者院内死亡率的独立预测因子。
Heart Rhythm. 2021 Apr;18(4):501-507. doi: 10.1016/j.hrthm.2021.01.018. Epub 2021 Jan 22.
5
Clinical Impact of Atrial Fibrillation on Short-Term Outcomes and In-Hospital Mortality in Patients with Takotsubo Syndrome: A Propensity-Matched National Study.应激性心肌病患者心房颤动对短期结局和住院死亡率的临床影响：一项倾向匹配的全国性研究
Cardiovasc Revasc Med. 2020 Apr;21(4):522-526. doi: 10.1016/j.carrev.2019.07.022. Epub 2019 Jul 23.
6
Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort.在一个多元化的纽约市队列中，COVID-19 死亡病例的临床和心脏特征。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3086-3096. doi: 10.1111/jce.14772. Epub 2020 Oct 20.
7
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection.2019冠状病毒病（COVID-19）感染住院患者的冠状动脉疾病
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001428.
8
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.COVID-19 综合征住院后血管紧张素转换酶抑制剂或血管紧张素 II 受体拮抗剂的预先给药与生存。
J Am Heart Assoc. 2020 Nov 17;9(22):e017364. doi: 10.1161/JAHA.120.017364. Epub 2020 Oct 7.
9
Registry Study Describes COVID-19 Mortality and Hospitalization in Patients with Breast Cancer.研究注册表明 COVID-19 对乳腺癌患者的死亡率和住院率的影响。
Oncologist. 2021 Feb;26 Suppl 2(Suppl 2):S17-S18. doi: 10.1002/onco.13664. Epub 2021 Jan 5.
10
Association of Follow-Up Care With Long-Term Death and Subsequent Hospitalization in Patients With Atrial Fibrillation Who Receive Emergency Care in the Province of Ontario.安大略省接受急诊治疗的房颤患者接受随访护理与长期死亡和随后住院的关系。
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e006498. doi: 10.1161/CIRCEP.118.006498. Epub 2019 Dec 16.
引用本文的文献
1
Individuals Recovered from Severe COVID-19 are Predispose to Develop Atrial Fibrillation.从重症新冠病毒疾病中康复的个体易患心房颤动。
Int J Gen Med. 2025 Aug 12;18:4379-4390. doi: 10.2147/IJGM.S527058. eCollection 2025.
2
Demographic trends in mortality with older population due to atrial fibrillation and flutter from 1999-2020.1999年至2020年老年人口因心房颤动和扑动导致的死亡率的人口统计学趋势。
World J Cardiol. 2025 Jan 26;17(1):99933. doi: 10.4330/wjc.v17.i1.99933.
3
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study.慢性HBV感染合并COVID-19肺炎住院患者的临床特征与转归：一项回顾性队列研究
Viruses. 2024 Dec 30;17(1):40. doi: 10.3390/v17010040.
4
A pooled analysis of the incidence and mortality risk of atrial fibrillation in patients with COVID-19.COVID-19 患者心房颤动的发生率和死亡率的汇总分析。
PeerJ. 2024 Oct 16;12:e18330. doi: 10.7717/peerj.18330. eCollection 2024.
5
SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs.SARS-CoV-2 ORF3a 介导的电流被抗心律失常药物抑制。
Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae252.
6
The Trends in Atrial Fibrillation-Related Mortality before, during, and after the COVID-19 Pandemic Peak in the United States.美国在新冠疫情高峰期之前、期间及之后与心房颤动相关的死亡率趋势
J Clin Med. 2024 Aug 15;13(16):4813. doi: 10.3390/jcm13164813.
7
Permanent and Persistent Atrial Fibrillations Are Independent Risk Factors of Mortality after Severe COVID-19.永久性和持续性心房颤动是重症 COVID-19 后死亡的独立危险因素。
J Clin Med. 2024 May 26;13(11):3112. doi: 10.3390/jcm13113112.
8
Incidence and prognostic significance of newly-diagnosed atrial fibrillation among older U.S. veterans hospitalized with COVID-19.美国 COVID-19 住院老年退伍军人中新诊断心房颤动的发生率和预后意义。
Sci Rep. 2024 Jan 10;14(1):952. doi: 10.1038/s41598-024-51177-6.
9
Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19.COVID-19患者新发房颤后的长期死亡率
J Clin Med. 2023 Apr 18;12(8):2925. doi: 10.3390/jcm12082925.
10
Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment.新冠后遗症中的心律失常：患病率、病理学、诊断与治疗。
Viruses. 2023 Jan 29;15(2):389. doi: 10.3390/v15020389.
本文引用的文献
1
COVID-19 and cardiac arrhythmias.新型冠状病毒肺炎与心律失常。
Heart Rhythm. 2020 Sep;17(9):1439-1444. doi: 10.1016/j.hrthm.2020.06.016. Epub 2020 Jun 22.
2
Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy.意大利按年龄组划分的因 COVID-19 住院死亡个体的临床特征。
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800. doi: 10.1093/gerona/glaa146.
3
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.意大利北部因 COVID-19 和心脏病住院患者的特征和结局。
Eur Heart J. 2020 May 14;41(19):1821-1829. doi: 10.1093/eurheartj/ehaa388.
4
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.COVID-19 与心血管系统：对风险评估、诊断和治疗选择的影响。
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687. doi: 10.1093/cvr/cvaa106.
Zotero 插件